comparemela.com

Page 2 - Next Science News Today : Breaking News, Live Updates & Top Stories | Vimarsana

In Case You Missed It - BC Extra Upgrades & Downgrades - 27-10-23

A summary of the highlights from Broker Call Extra updates throughout the week past

New south walesKathleen valleyWestern australiaJames hardie industriesEquity holdingsWeekly reportsRating changesThursday last weekMarket weightLiontown resourcesJanison educationNext science

In Case You Missed It - BC Extra Upgrades & Downgrades - 15-09-23

Starting today, FNArena is publishing a summary of the highlights from Broker Call Extra updates throughout the week past

Canaccord genuityMayne pharmaWeekly reportsBroker call extraRating changesPost fridayMarket weightNext scienceLeo lithiumMining code

Australian Broker Call Extra Edition - Sep 11, 2023

Extra Edition of the Broker Call Report

Bald hillNew south walesPharmaceuticals biotech lifesciencesGoldman sachsDaily market reportsAustralian broker call reportAustralian broker callLicenced advisorPetra capitalEarnings ratioMarket weightNext science

Next Science First Half 2023 Earnings: US$0 04 loss per share (vs US$0 032 loss in 1H 2022)

Next Science ( ASX:NXS ) First Half 2023 Results Key Financial Results Revenue: US$10.1m (up 87% from 1H 2022). Net.

Medical equipmentNext scienceRevenue growthNet lossText science

Biotech Next Science raising $29m

Next Science, owner of medical solutions to prevent surgical and wound infections, launched a $28.9 million raising on Tuesday morning split across five legs.

Canaccord genuityWalker groupNext scienceWilsons corporate finance

vimarsana © 2020. All Rights Reserved.